Prolexys Pharmaceuticals
2150 West Dauntless Avenue
Salt Lake City
UT
84116
801 303 1700

Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications. Prolexys scientists have exploited proprietary proteomics-related techniques to rapidly and accurately identify drug candidates that interact with targets of interest. The result of targeted drug discovery work at Prolexys is a pipeline of product candidates with high value in areas of unmet medical need.

Recent Interviews

Deal Flow

Fundings

Closing Date Round Amount
11/06/2008 Series A $20,000,000
07/30/2008 Unattributed $15,000,000
08/01/2006 Unattributed $9,400,000
04/01/2001 Seed $82,000,000

Mergers & Acquisitions

Public Offerings

News

Press

Company Video

Company Snapshot

Yes
Biotechnology | Pharmaceutical
Active
Not Assigned
$2,000,000
$126,400,000
Link
Link
30
30

Key People

Similar Companies


Legal Disclaimer